Paul C. Tang (@PaulTangMD) header
Paul C. Tang (@PaulTangMD) profile picture

Cardiac Surgeon | Heart Transplant, Mechanical Circulatory Support, Outcomes Research & Biotechnology | Lab: https://nitter.cf/t.co/w2bHR9VVCS | @MayoClinicCVS | Tweets are my own

Joined December 2018
Photo by Paul C. Tang (@PaulTangMD)Photo by Paul C. Tang (@PaulTangMD)Photo by Paul C. Tang (@PaulTangMD)Photo by Paul C. Tang (@PaulTangMD)Photo by Paul C. Tang (@PaulTangMD)Photo by Paul C. Tang (@PaulTangMD)Photo by Paul C. Tang (@PaulTangMD)Photo by Paul C. Tang (@PaulTangMD)Photo by Paul C. Tang (@PaulTangMD)Photo by Paul C. Tang (@PaulTangMD)
Hope this video helps to clarify how receptor phase separation influences organ preservation quality. @MayoClinicCVS @MayoTransplant #PhaseSeparation
3
3
6
423
Paul C. Tang retweeted
Donation after brain and cardiac death leads to differential cell-specific cardiac signaling. An improved understanding of this process can lead to more targeted cardiac preservation techniques for each mode of donation. @PaulTangMD 🔗: jhltonline.org/article/S1053…
1
4
9
686
Congratulations I. Lei, PhD, Asst Prof of Physiology & Biomedical Engineering, on being awarded his second R01! This grant supports research exploring how gene organization w/in the nucleus influences age-related susceptibility of donor hearts to preservation injury. @PaulTangMD
1
7
661
Attending #ASC2026? Join @SinaDaneshMD as he presents, "Impact of BMI on Outcomes Following Surgical vs. TAVR", Wed., Feb. 4 @ 8AM! @PaulTangMD
2
1
13
2,404
Paul C. Tang retweeted
New mechanical circulatory support research: Active and passive cardiac indexes as complementary predictors of outcomes after left ventricular assist device implantation. Log in to your #JTCVS account to read more: doi.org/10.1016/j.jtcvs.2025… @PaulTangMD @MayoClinicCVS
2
5
15
1,099
Paul C. Tang retweeted
New in mechanical circulatory support: Influence of postimplant mitral regurgitation on durable left ventricular assist device outcomes. Learn more from @JundraPeguesMD, @PaulTangMD et al in this #JTCVS article: doi.org/10.1016/j.jtcvs.2025…
3
8
1,161
Thrilled to share our recent work published in #JTCVS Exploring outcomes of #TEER vs surgical correction of #mitral regurgitation in advanced age 🫀 Grateful to Drs @Arghami, @PaulTangMD & @HSchaffMD for their mentorship @MayoClinicCVS @AATSHQ
3
3
21
1,242
Thrilled to share our work published in Circulation as part of @AHAScience We investigated how aortic annular area influences outcomes after balloon-expandable vs. self-expandable valve-in-valve TAVR. Grateful to Dr. @PaulTangMD and the great team @MayoClinicCVS
2
22
1,398
Very well deserved recognition for our NP/PA lead, Marci Newcome, DNP. Always going above and beyond!
Congratulations to @MarciNewcome DNP, APRN, CNP, Director of CVS NPPAs-2025 Fellow of APPex! The Fellowship of APPex is the first & only honorary recognition that formally acknowledges APRN & PA administrators & leaders who’ve made exceptional contributions to advanced practice.
1
1
3
1,003
Congratulations to @MarciNewcome DNP, APRN, CNP, Director of CVS NPPAs-2025 Fellow of APPex! The Fellowship of APPex is the first & only honorary recognition that formally acknowledges APRN & PA administrators & leaders who’ve made exceptional contributions to advanced practice.
4
1
7
1,450
Mineralocorticoid receptor inhibition at the time of cardiac surgery may reduce postop new atrial fibrillation. Opportunities exist to trial this in patients. Congrats to @SinaDaneshMD who worked intensely on this article. @MayoClinicCVS @MayoCVservices @AHAScience
Mineralocorticoid receptor antagonists reduce post-heart surgery atrial fibrillation (#AFib), likely by acting on cardiomyocytes. #AHAJournals @SinaDaneshMD @PaulTangMD @MayoClinicCVS ahajrnls.org/3JeRBs5
2
1
10
4,508
I. Lei, PhD, Asst Prof of Physiology & Biomedical Engineering @MayoClinicCVS, received an RO1, titled, "Epigenetic regulation of donor heart preservation mediated by Brd4", focusing on delving deeper into the mechanisms w/aim to bring Brd4 drug therapy into the transplant field.
1
1
3
682
Dr. Carmelo Milano was named 2025 John W. Kirklin Visiting Professor in Cardiac Surgery. Dr. Milano is the Division Chief of Cardiothoracic Surgery at Duke University Medical Center. @JuanCrestanello
3
2
30
3,596
Check out this interesting #JAHA article where research experts share their findings. @PaulTangMD
Our paper in JAHA @MayoClinicCVS Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post‐Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest | Journal of the American Heart Association ahajournals.org/doi/10.1161/…
1
3
1,186
Thrilled to share our manuscript in @JAHA_AHA on linking clinical outcomes to molecular insights of AF 👥 19042 Patients 💊 Preop MRA use → ⬇️ Post-op & long-term AF 🧬 snRNA-seq → MRAs suppress atrial stress responses 🔗 ahajournals.org/doi/full/10.… @PaulTangMD @MayoClinicCVS
6
5
46
3,401
Excited to share our new paper in #JTCVS 👥 3265 SAVR±CABG (2000–2024) 📉 Mechanical valves→ survival benefit only in larger EOA metrics 🫀 Also assessed AV reintervention, HF readmission, stroke & major bleeding 👉 doi.org/10.1016/j.jtcvs.2025… @PaulTangMD @MayoClinicCVS @AATSHQ
3
5
37
3,984
Listen to this podcast featuring @PaulTangMD, "A heartwarming Tale: How Basic Research into Cell Behavior Spurred an Advance in Transplant Surgery" #telluridescience bit.ly/457OPfk
6
28
1,119
More discussions on this podcast with journalists George Lewis & Judy Muller on @telluridesci and “Science straight Up”. Huge thanks to Rohit Pappu at Wash U for the in-depth scientific insight on phase separated states. telluridescience.org/podcast… buzzsprout.com/1204337/episo…
Sharing our NCVR article demonstrating how donor heart ischemic tolerance and functional performance can be enhanced by reducing mineralocorticoid receptor phase separation. A clinically utilized MR antagonist, Canrenone, is available now to accomplish this.
1
1
11
1,118
Sharing our NCVR article demonstrating how donor heart ischemic tolerance and functional performance can be enhanced by reducing mineralocorticoid receptor phase separation. A clinically utilized MR antagonist, Canrenone, is available now to accomplish this.
1
5
1,451
Heartfelt thanks to Ienglam Lei & all collaborators on this very exciting trip down the rabbit hole of organ preservation biology. So many impactful avenues for molecular science to explore in modern surgery. We thank all who supported including @AATSHQ @ThoracicSurgFnd and NIH
2
2
17
2,140